1. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In Holmes KK, Sparling PF, et al, Sexually Transmitted Diseases 4th ed. New York, NY. McGraw Hill 2008; 627-45.
2. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996;72:422-6.
3. Taylor SN, DiCarlo RP, Martin DH. Comparison of methylene blue/gentian violet stain to Gram’s stain for the rapid diagnosis of gonococcal urethritis in men. Sex Trans Dis 2011;38:995-6
4. Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin Med 1997;73: 245-52
5. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751-6.
6. Cook RL, Hutchison SL, 0stergaard L,Braithwaite RS, Ness RB. Systematic Review: Non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25
7. Van der Pol B, Ferrero DV, Buck-Barrington L, Hook EW 3rd, Lenderman C, Quinn TC, et al. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical and male urethral swabs. J Clin Microbiol 2001;39:1008-16.
8. Walsh A, Rourke FO, Crowley B. Molecular detection and confirmation of Neisseria gonorrhoeae in urogenital and extragenital specimens using the Abbott CT/NG RealTime assay and an in-house assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis 2011 Apr;30(4):561-7.
9. Shipitsyna E, Zolotoverkhaya E, Hjelmevoll SO, et al. Evaluation of six nucleic acid amplification tests used for diagnosis of Neisseria gonorrhoeae in Russia compared with an international strictly validated real-time porA pseudogene polymerase chain reaction. J Eur Acad Dermatol Venereol 2009 Nov;23(11):1246-53.
10. Цеслюк МВ, Гущин АЕ, Савочкина ЮА, Быков АС, Шипулин ГА. Сравнение методов лабораторной диагностики гонореи с применением "расширенного золотого стандарта". Клиническая лабораторная диагностика 2008(7):48-53.
11. Moran JS, Levine WC. Drugs of choice in the treatment of uncomplicated gonococcal infection. Clin Infect Dis 1995;20(Suppl 1):S47-65.
12. Bignell C, Fitzgerald M, BASHH Guideline Development Group. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS 2011;22:541-7.
13. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR 2010;59(No. RR-12):49-55.
14. CDC. Sexually Transmitted Diseases Surveillance 2012. Atlanta: US Department of Health and Human Services; 2015; avaliable at: http://www.cdc.gov/std/tg2015/gonorrhea.htm. (https://docviewer.yandex.ruZr.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
15. Sexually Transmitted Diseases Treatment Guidelines, 2015 MMWR/June 5, 2015/Vol. 64/No. 3. (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
16. Yu RX, Yin Y, Wang GQ, et al. Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis. PLoS One 2014;9:e87849. (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
17. Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 2007;13:1275-7. (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
18. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis. Otolaryngol Head Neck Surg 2007; 136:340-7 (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
19. Рахматулина М.Р. Гонококковая инфекция: тактика диагностики и терапии согласно российским и зарубежным клиническим рекомендациям. - 2015. - № 2. - С.41-48. (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb
20. European Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults 2012; avaliable at: (https://docviewer.yandex.ru/r.xml? sk=be7b20a92cacd9bcfd76664575198cc8&url=https%3A%2F%2Fdocviewer.yandex.ru%2Fr.xml%3Fsk%3Db5a80b2bab5a6d53661bb (http ://www.iusti. org/regions/Europe/pdf/2012/Gonorrhoea_2012 .pdf)
21. Haimovici R, Roussel TJ. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am J Ophthalmol 1989;107:511-4. (http://www.iusti.org/regions/Europe/pdf/2012/Gonorrhoea_2012.pdf)
22. Bleich AT, Sheffield JS, Wendel GD Jr, Sigman A, Cunningham FG. Disseminated gonococcal infection in women. Obstet Gynecol 2012;119:597-602. (http://www.iusti.org/regions/Europe/pdf/2012/Gonorrhoea_2012.pdf)
23. O’Brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: aprospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine1983;62:395-406 (http ://www.iusti. org/regions/Europe/pdf/2012/Gonorrhoea_2012 .pdf)
24. Wise CM, Morris CR, Wasilauskas BL, Salzer WL. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med1994;154: 2690-5. (http ://www.iusti. org/regions/Europe/pdf/2012/Gonorrhoea_2012 .pdf)
25. Thompson SE. Treatment of disseminated gonococcal infections. Sex Transm Dis1979;6 (Suppl 1):181. (http ://www.iusti. org/regions/Europe/pdf/2012/Gonorrhoea_2012 .pdf)
26. Ramus RM, Sheffield JS, Mayfield JA, Wendel GD. A randomised trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhoea in pregnancy. Am J Obstet Gynecol 2001;185: 629-32. (http ://www.iusti. org/regions/Europe/pdf/2012/Gonorrhoea_2012 .pdf)